Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation
NCT ID: NCT04173091
Last Updated: 2020-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2013-01-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation
NCT05820516
Tricuspid RegUrgitaTion Hamburg Cohort
NCT04755842
German Registry for Transcatheter Tricuspid Valve Interventions
NCT04653428
Right VEntricular Contractile ReSERVE in Functional Tricuspid Regurgitation
NCT04141683
Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation
NCT01502462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
No Intervention planed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander Lauten
Professor, Head of Cardiac catheterization Laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brunilda Alushi
Berlin, , Germany
Contilia Heart and Vascular Centre
Essen, , Germany
Department of Internal Medicine and Cardiology, Heart Centre Leipzig
Leipzig, , Germany
German Heart Centre
Munich, , Germany
Rabin Medical Centre
Tel Aviv, Petah Tikva, Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRuE012013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.